98%
921
2 minutes
20
Background: Surrogate outcomes are often utilized when disease outcomes are difficult to directly measure. When a biological threshold effect exists, surrogate outcomes may only represent disease in specific subpopulations. We refer to these outcomes as "partial surrogate outcomes." We hypothesized that risk models of partial surrogate outcomes would perform poorly if they fail to account for this population heterogeneity. We developed criteria for predictive model development using partial surrogate outcomes and demonstrate their importance in model selection and evaluation within the clinical example of serum creatinine, a partial surrogate outcome for acute kidney injury.
Methods: Data from 4737 patients who underwent cardiac surgery at a major academic center were obtained. Linear and mixture models were fit on maximum 2-day serum creatinine change as a surrogate for estimated glomerular filtration rate at 90 days after surgery (eGFR90), adjusted for known AKI risk factors. The AUC for eGFR90 decline and Spearman's rho were calculated to compare model discrimination between the linear model and a single component of the mixture model deemed to represent the informative subpopulation. Simulation studies based on the clinical data were conducted to further demonstrate the consistency and limitations of the procedure.
Results: The mixture model was highly favored over the linear model with BICs of 2131.3 and 5034.3, respectively. When model discrimination was evaluated with respect to the partial surrogate, the linear model displays superior performance ( < 0.001); however, when it was evaluated with respect to the target outcome, the mixture model approach displays superior performance (AUC difference = 0.002; Spearman's difference = 0.020). Simulation studies demonstrate that the nature of the heterogeneity determines the magnitude of any advantage the mixture model.
Conclusions: Partial surrogate outcomes add complexity and limitations to risk score modeling, including the potential for the usual metrics of discrimination to be misleading. Partial surrogacy can be potentially uncovered and appropriately accounted for using a mixture model approach. Serum creatinine behaved as a partial surrogate outcome consistent with two patient subpopulations, one representing patients whose injury did not exceed their renal functional reserve and a second population representing patients whose injury did exceed renal functional reserve.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460789 | PMC |
http://dx.doi.org/10.1186/s41512-017-0022-1 | DOI Listing |
JTO Clin Res Rep
September 2025
Stanford Cancer Institute, Stanford University, Stanford, California.
Immune checkpoint inhibitors provide clinical benefit to a subset of patients with metastatic NSCLC, yet the reliable prediction of long-term outcomes remains challenging. We conducted a prospective phase 2 clinical trial to evaluate circulating tumor DNA (ctDNA) as a surrogate biomarker for early clinical response to pembrolizumab monotherapy (NCT02955758). Tumor-informed targeted sequencing of pretreatment and early on-treatment plasma ctDNA in 25 patients with metastatic NSCLC was performed.
View Article and Find Full Text PDFSensors (Basel)
August 2025
School of Innovation, Design and Engineering, Mälardalen University, 722 20 Västerås, Sweden.
In cyber-physical systems governed by nonlinear partial differential equations (PDEs), real-time control is often limited by sparse sensor data and high-dimensional system dynamics. Deep reinforcement learning (DRL) has shown promise for controlling such systems, but training DRL agents directly on full-order simulations is computationally intensive. This paper presents a sensor-driven, non-intrusive reduced-order modeling (NIROM) framework called FAE-CAE-LSTM, which combines convolutional and fully connected autoencoders with a long short-term memory (LSTM) network.
View Article and Find Full Text PDFBackground: Antipsychotic medications are frequently prescribed to older residents of long-term care facilities (LTCFs) despite their limited efficacy and considerable safety risks. While discontinuation of these drugs might help reduce their associated morbidity, the impact of stopping antipsychotics on the risk of hospitalization has not been studied yet. The study aimed at estimating the effect of antipsychotic discontinuation on the risk of hospitalization in older LTCF residents and at identifying relevant factors influencing such effect.
View Article and Find Full Text PDFAnn Clin Transl Neurol
August 2025
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Objective: To identify metabolic patterns in the brain and musculoskeletal system of stiff person syndrome spectrum disorders (SPSD) patients over time using PET imaging and evaluate the impact of immune therapy on metabolic activity as a surrogate for treatment response.
Methods: This observational study at the Johns Hopkins SPS Center of Excellence included adults (≥ 18 years) diagnosed with classic SPS, partial SPS, SPS plus, or PERM, who were treated from 2009 to 2023. Participants underwent at least two whole-body and/or dedicated brain PET scans.
Ann Dermatol Venereol
August 2025
Dermatology Department, CHU Tours, Institut Dermatologique du Grand Ouest (IDGO), Avenue de la République, 37170 Tours Cedex, France. Electronic address:
Background: Advanced Merkel cell carcinoma (MCC) has been shown to be effectively targeted by PD-1/PD-L1 inhibitors in phase II trials and real-world studies. More than 50% of MCC patients display resistance to PD-1/PD-L1 inhibitors while identification of predictive factors for response has been inconclusive so far in this population. Our primary objective was to assess overall survival (OS) in a real-world cohort of advanced MCC patients treated with PD(L)1 inhibitors in France.
View Article and Find Full Text PDF